BACKGROUND: Human immunodeficiency virus (HIV) and sexually transmitted infections (STI) are prevalent among men who have sex with men (MSM). GOAL: To estimate the prevalence of HIV and STIs in this group. STUDY: A total of 694 MSM were tested for HIV, hepatitis B (HBV), hepatitis C (HCV), human T-cell lymphotropic (HTLV-I/II) viruses and Treponema pallidum infection. RESULTS: HIV, HBV, and T pallidum were detected in 13.8%, 37.7%, and 16.9% of subjects, respectively. Prevalences of 1.9% and 0.3% were detected for HCV and HTLV-I/II. A prior history of STI was the most predictor for HIV, HBV, and T pallidum. Use of illegal drugs, blood transfusion history, and multiple sexual partners were associated with HCV. The 2 most common co-infections were HBV/T pallidum and HIV/HBV. CONCLUSIONS: Infection with HIV, HBV, and T pallidum was elevated among MSM. Routine testing, education, vaccine-based prevention, and control programs need to be implemented in this high-risk population.
BACKGROUND:Humanimmunodeficiency virus (HIV) and sexually transmitted infections (STI) are prevalent among men who have sex with men (MSM). GOAL: To estimate the prevalence of HIV and STIs in this group. STUDY: A total of 694 MSM were tested for HIV, hepatitis B (HBV), hepatitis C (HCV), human T-cell lymphotropic (HTLV-I/II) viruses and Treponema pallidum infection. RESULTS:HIV, HBV, and T pallidum were detected in 13.8%, 37.7%, and 16.9% of subjects, respectively. Prevalences of 1.9% and 0.3% were detected for HCV and HTLV-I/II. A prior history of STI was the most predictor for HIV, HBV, and T pallidum. Use of illegal drugs, blood transfusion history, and multiple sexual partners were associated with HCV. The 2 most common co-infections were HBV/T pallidum and HIV/HBV. CONCLUSIONS: Infection with HIV, HBV, and T pallidum was elevated among MSM. Routine testing, education, vaccine-based prevention, and control programs need to be implemented in this high-risk population.
Authors: Javier R Lama; Hellen S Agurto; Juan V Guanira; Carmela Ganoza; Martin Casapia; Nora Ojeda; Abner Ortiz; Victoria Zamalloa; Luis Suarez-Ognio; Cesar Cabezas; Jose L Sanchez; Jorge Sanchez Journal: Am J Trop Med Hyg Date: 2010-07 Impact factor: 2.345
Authors: Carlos Zala; Clare A Rustad; Keith Chan; Nabeela I Khan; Marcelo Beltran; Eduardo Warley; Mariana Ceriotto; Eric F Druyts; Robert S Hogg; Julio Montaner; Pedro Cahn Journal: Medscape J Med Date: 2008-04-02
Authors: Alberto M La Rosa; Joseph R Zunt; Jesus Peinado; Javier R Lama; Thanh G N Ton; Luis Suarez; Monica Pun; Cesar Cabezas; Jorge Sanchez Journal: Clin Infect Dis Date: 2009-07-01 Impact factor: 9.079
Authors: María A Pando; Iván C Balán; Rubén Marone; Curtis Dolezal; Cheng-Shiun Leu; Luis Squiquera; Victoria Barreda; Marcelo Rodriguez Fermepín; Lucia Gallo Vaulet; Jorge Rey; María Picconi; Alex Carballo-Diéguez; María M Avila Journal: PLoS One Date: 2012-06-29 Impact factor: 3.240
Authors: Monica Alonso; Annika Gutzman; Rafael Mazin; Carlos E Pinzon; Ludovic Reveiz; Massimo Ghidinelli Journal: Int J Public Health Date: 2015-08-23 Impact factor: 3.380
Authors: Carlos Zala; Clare A Rustad; Keith Chan; Nabeela I Khan; Marcelo Beltran; Eduardo Warley; Mariana Ceriotto; Eric F Druyts; Robert S Hogg; Julio Montaner; Pedro Cahn Journal: J Int AIDS Soc Date: 2008-04-02 Impact factor: 5.396
Authors: Jesse L Clark; Carlos F Caceres; Andres G Lescano; Kelika A Konda; Segundo R Leon; Franca R Jones; Susan M Kegeles; Jeffrey D Klausner; Thomas J Coates Journal: PLoS One Date: 2007-08-22 Impact factor: 3.240